UBS has downgraded Forvia from Buy to Neutral, lowering its price target from €13 to €9, citing significant uncertainty and limited balance sheet flexibility. The firm warns that weak free cash flow, lack of volume growth, and strong cost pressures may hinder profit margins and lead to potential balance sheet weaknesses. In related news, Valeo is also facing challenges, with forecasts of plant closures and job cuts in Europe, reflecting the broader struggles within the automotive sector.